Walter Joseph Simoneaux Jr, MD | |
504 N Acadia Rd, Thibodaux, LA 70301-4862 | |
(985) 448-3055 | |
(985) 447-5670 |
Full Name | Walter Joseph Simoneaux Jr |
---|---|
Gender | Male |
Speciality | Urology |
Experience | 18 Years |
Location | 504 N Acadia Rd, Thibodaux, Louisiana |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1225076185 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208800000X | Urology | MD025595 (Louisiana) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Thibodaux Regional Medical Center | Thibodaux, LA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Thibodaux Regional Network Development Corporation | 8224011754 | 97 |
News Archive
Quidel Corporation, a global leader in point-of-care (POC) rapid diagnostic tests, issues clarification regarding the Special 510(k) clearance for an update to the Company's QuickVue Influenza A+B test package insert.
Ontario's Community Pharmacies Coalition are extremely disappointed by yesterday's announcement by Health Minister Deb Matthews and the posting of amendments to regulations under the OBDA and DIDFA as it all but assures that Ontario patients will be less able to freely access the front-line community healthcare they have come to rely on.
Discontinuing the anemia drug epoetin may be more effective than reducing the dose for normalizing potentially dangerous high hemoglobin levels in hemodialysis patients, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology. The results provide useful information about the balance required between administering epoetin and achieving target hemoglobin levels.
Lannett Company, Inc., a manufacturer of generic pharmaceuticals, today announced that it recently met with the U.S. Food and Drug Administration (FDA) to discuss the status of the company's New Drug Application (NDA) for Morphine Sulfate Oral Solution as well as other pending product applications.
› Verified 7 days ago
Entity Name | Thibodaux Regional Network Development Corporation |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1285658310 PECOS PAC ID: 8224011754 Enrollment ID: O20040608000132 |
News Archive
Quidel Corporation, a global leader in point-of-care (POC) rapid diagnostic tests, issues clarification regarding the Special 510(k) clearance for an update to the Company's QuickVue Influenza A+B test package insert.
Ontario's Community Pharmacies Coalition are extremely disappointed by yesterday's announcement by Health Minister Deb Matthews and the posting of amendments to regulations under the OBDA and DIDFA as it all but assures that Ontario patients will be less able to freely access the front-line community healthcare they have come to rely on.
Discontinuing the anemia drug epoetin may be more effective than reducing the dose for normalizing potentially dangerous high hemoglobin levels in hemodialysis patients, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology. The results provide useful information about the balance required between administering epoetin and achieving target hemoglobin levels.
Lannett Company, Inc., a manufacturer of generic pharmaceuticals, today announced that it recently met with the U.S. Food and Drug Administration (FDA) to discuss the status of the company's New Drug Application (NDA) for Morphine Sulfate Oral Solution as well as other pending product applications.
› Verified 7 days ago
Entity Name | Simoneaux Urology Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1225064348 PECOS PAC ID: 2163435025 Enrollment ID: O20060718000096 |
News Archive
Quidel Corporation, a global leader in point-of-care (POC) rapid diagnostic tests, issues clarification regarding the Special 510(k) clearance for an update to the Company's QuickVue Influenza A+B test package insert.
Ontario's Community Pharmacies Coalition are extremely disappointed by yesterday's announcement by Health Minister Deb Matthews and the posting of amendments to regulations under the OBDA and DIDFA as it all but assures that Ontario patients will be less able to freely access the front-line community healthcare they have come to rely on.
Discontinuing the anemia drug epoetin may be more effective than reducing the dose for normalizing potentially dangerous high hemoglobin levels in hemodialysis patients, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology. The results provide useful information about the balance required between administering epoetin and achieving target hemoglobin levels.
Lannett Company, Inc., a manufacturer of generic pharmaceuticals, today announced that it recently met with the U.S. Food and Drug Administration (FDA) to discuss the status of the company's New Drug Application (NDA) for Morphine Sulfate Oral Solution as well as other pending product applications.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Walter Joseph Simoneaux Jr, MD 504 N Acadia Rd, Thibodaux, LA 70301-4862 Ph: (985) 448-3055 | Walter Joseph Simoneaux Jr, MD 504 N Acadia Rd, Thibodaux, LA 70301-4862 Ph: (985) 448-3055 |
News Archive
Quidel Corporation, a global leader in point-of-care (POC) rapid diagnostic tests, issues clarification regarding the Special 510(k) clearance for an update to the Company's QuickVue Influenza A+B test package insert.
Ontario's Community Pharmacies Coalition are extremely disappointed by yesterday's announcement by Health Minister Deb Matthews and the posting of amendments to regulations under the OBDA and DIDFA as it all but assures that Ontario patients will be less able to freely access the front-line community healthcare they have come to rely on.
Discontinuing the anemia drug epoetin may be more effective than reducing the dose for normalizing potentially dangerous high hemoglobin levels in hemodialysis patients, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology. The results provide useful information about the balance required between administering epoetin and achieving target hemoglobin levels.
Lannett Company, Inc., a manufacturer of generic pharmaceuticals, today announced that it recently met with the U.S. Food and Drug Administration (FDA) to discuss the status of the company's New Drug Application (NDA) for Morphine Sulfate Oral Solution as well as other pending product applications.
› Verified 7 days ago
Dr. Stephanie Elaine Hughes, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 504 N Acadia Rd, Thibodaux, LA 70301 Phone: 985-447-5667 | |
Dr. Thomas Edward Dukovac, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 504 N Acadia Rd, Thibodaux, LA 70301 Phone: 985-447-5667 Fax: 985-447-5670 | |
P Truett Ray Jr., M.D Urology Medicare: Not Enrolled in Medicare Practice Location: 504 N Acadia Rd, Thibodaux, LA 70301 Phone: 985-447-5667 Fax: 985-447-5670 | |
Chester Frank Weimer, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 504 N Acadia Rd, Thibodaux, LA 70301 Phone: 985-448-3055 Fax: 985-447-5670 |